DSCAM-AS1 and breast carcinoma: Conversely, 56.7% of the top 60 down-regulated genes were known oncogenes (Fig 1L and Table S1), among which are the lncRNAs DSCAM-AS1, a luminal marker involved in breast cancer progression (23, 24), and LINC00052, an anchorage-independent growth promoter ((25); Fig 1M).